Myoglobin (MYO) Detection Kit

The Myoglobin (MYO) Detection Kit uses chemiluminescence immunoassay (CLIA) technology to quantitatively measure myoglobin in human serum, aiding in early myocardial infarction (MI) diagnosis and muscle condition monitoring. With a detection range of 1.0–1200.0 ng/mL and compatibility with multiple analyzers, it provides rapid, sensitive results within 2–4 hours post-MI.

 

Description

The Myoglobin (MYO) Detection Kit is an advanced diagnostic tool designed for the quantitative measurement of myoglobin levels in human serum. Utilizing cutting-edge chemiluminescence immunoassay (CLIA) technology, the kit offers exceptional sensitivity, enabling early detection of myocardial infarction (MI) within 2–4 hours post-event. It features a broad detection range of 1.0–1200.0 ng/mL and compatibility with a variety of analyzers, ensuring versatility and ease of use in clinical settings.

Myoglobin, a key biomarker for ischemic heart disease and muscle injuries, provides critical diagnostic value, particularly when elevated levels are identified early. The kit’s results are traceable to standardized methods, enhancing diagnostic reliability. For accurate interpretation, results should be considered alongside clinical data and other relevant biomarkers.

Reviews

There are no reviews yet.

Be the first to review “Myoglobin (MYO) Detection Kit”

Your email address will not be published. Required fields are marked *